Your browser doesn't support javascript.
loading
Characterizing chromatin landscape from aggregate and single-cell genomic assays using flexible duration modeling.
Gabitto, Mariano I; Rasmussen, Anders; Wapinski, Orly; Allaway, Kathryn; Carriero, Nicholas; Fishell, Gordon J; Bonneau, Richard.
Afiliação
  • Gabitto MI; Center for Computational Biology, Flatiron Institute, Simons Foundation, New York, NY, 10010, USA. mgabitto@flatironinstitute.org.
  • Rasmussen A; Center for Computational Biology, Flatiron Institute, Simons Foundation, New York, NY, 10010, USA.
  • Wapinski O; New York University, Neuroscience Institute and the Department of Neuroscience and Physiology, Smilow Research Center, New York, NY, 10016, USA.
  • Allaway K; Department of Neurobiology, Harvard Medical School, Boston, MA, 02115, USA.
  • Carriero N; Stanley Center at the Broad, Cambridge, MA, 02142, USA.
  • Fishell GJ; New York University, Neuroscience Institute and the Department of Neuroscience and Physiology, Smilow Research Center, New York, NY, 10016, USA.
  • Bonneau R; Department of Neurobiology, Harvard Medical School, Boston, MA, 02115, USA.
Nat Commun ; 11(1): 747, 2020 02 06.
Article em En | MEDLINE | ID: mdl-32029740
ATAC-seq has become a leading technology for probing the chromatin landscape of single and aggregated cells. Distilling functional regions from ATAC-seq presents diverse analysis challenges. Methods commonly used to analyze chromatin accessibility datasets are adapted from algorithms designed to process different experimental technologies, disregarding the statistical and biological differences intrinsic to the ATAC-seq technology. Here, we present a Bayesian statistical approach that uses latent space models to better model accessible regions, termed ChromA. ChromA annotates chromatin landscape by integrating information from replicates, producing a consensus de-noised annotation of chromatin accessibility. ChromA can analyze single cell ATAC-seq data, correcting many biases generated by the sparse sampling inherent in single cell technologies. We validate ChromA on multiple technologies and biological systems, including mouse and human immune cells, establishing ChromA as a top performing general platform for mapping the chromatin landscape in different cellular populations from diverse experimental designs.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cromatina / Genômica / Modelos Genéticos Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cromatina / Genômica / Modelos Genéticos Idioma: En Ano de publicação: 2020 Tipo de documento: Article